CLINICAL_TRIALS
trial_result
· 2020-12-16
Clinical Trial Update: Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer [Phase 2]
Summary
A multi-center Phase 2 randomized trial is investigating irreversible electroporation (IRE) for ablation of localized prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Clinical Research Office of the Endourological Society | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN